March 18th, 2015
Gallium(III) 5,10,15-(tris)pentafluorophenylcorrole and its freebase analogue exhibit low micromolar cell cytotoxicity. This manuscript describes an RNA transcription reaction, imaging RNA with an ethidium bromide-stained gel, and quantifying RNA with UV-Vis spectroscopy, in order to assess transcription inhibition by corroles and demonstrates a straightforward method of evaluating anticancer candidate properties.
The overall goal of this procedure is to determine if potential anti-cancer compounds inhibit rib nucleic acid, or RNA transcription. This is accomplished by first preparing RNA transcription reactions, including potential inhibitors in this experiment, CHO compounds which exhibit differential cytotoxic properties are investigated for inhibition of RNA transcription and compare to known inhibitors. After mixing the reactions thoroughly, the reaction tubes are incubated At 37 degrees Celsius and aliquots are removed at desired time points.
Next gel electrophoresis is used to assess relative inhibition because a iridium bromide fluoresces upon binding of RNA, darker bands in the gel correspond to higher concentrations of RNA. To quantitate the extent of transcription inhibition, ultraviolet, visible, or UV vs spectroscopy is performed. Ultimately, this video demonstrates a straightforward method for evaluating anti-cancer candidate properties.
Through assessing transcription inhibition by corals, Potential anti-cancer drugs should be evaluated for their ability to inhibit RNA.Transcription. Human cancer cells frequently become dependent on a single activated oncogene for survival treatments. Blocking the expression of the oncogenes are effective in eliminating cancer cells.
The RNA transcription inhibition procedure described here is a useful way to identify potential anti-cancer drug candidates and learn more about their mechanism of action. To begin prepare the Carole and inhibitor compounds in a 0.01 to one molar ratio of complex to DNA. To do this dissolve cin d Tripoli, TPFC and gallium TPFC and dimethyl sulf oxide in clean separate containers.
Obtain the final concentration by using cereal dilution with nuclease free water prior to beginning the transcription reaction. Prepare the necessary reagents individually or purchase them from a commercial vendor. Thaw all the frozen reagents on ice.
Then combine the reagents for the transcription reaction at room temperature as described in the text protocol. Mix thoroughly by flicking the tube or pipetting the mixture up and down gently before incubating the reaction mixture at 37 degrees Celsius. Next, remove four microliter aliquots from each reaction after each hour and store at minus 20 degrees Celsius, modifying as needed for desired time points following the transcription reaction.
Purify the RNA from the other reaction components using the RNA spin columns as described in the text protocol to perform agros gel electrophoresis prepare tris acetate EDTA or TAE running buffer and a 1000 x stock solution of Etherium bromide. And as described in the text protocol, always wear appropriate protective equipment when working with Etherium bromide as it is toxic. Next, prepare a 1%aros gel by dissolving 10 grams of ultrapure agros in one liter of one XTAE buffer and melting the agros with a conventional microwave oven.
Once it is cooled to 50 degrees Celsius, add one milliliter of 1000 x iridium bromide to the 1%agros gel solution and mix by gently swirling or by inverting in a closed container. Then pour the agro solution into a gel casting platform and allow the gel to solidify at room temperature after the gel has solidified. Remove the wedges from the electrophoresis tank and add enough TAE buffer to cover the gel until the wells are submerged.
Check that the level of the TAE buffer is approximately one millimeter above the level of the gel before removing the gel comb. To prepare the RNA samples for gel electrophoresis, combine one microliter of each purified sample aliquot with one microliter of gel loading buffer mixed thoroughly by pipetting up and down with a micro pipette load the gel with each sample by carefully pipetting the solution into the bottom of each. Well take care not to leave any air bubbles or mix samples between wells.
Attach the leads so that the DNA will migrate into the gel towards the positive lead. Set the voltage to the desired level. Typically one to 10 volts per centimeter of gel.
A 23 centimeter by 25 centimeter gel at 250 volts will run for approximately one hour. An eight centimeter by eight centimeter gel at 150 volts will run for approximately 20 minutes. Smaller, RNA fragments run at better resolution at higher voltages.
Run the gel for however long is sufficient for significant separation between potential RNA fragments using the migration of dyes to monitor the progress of the separation. Turn off the power supply before the dye from the loading buffer has migrated to the end of the gel image. The RNA under ultraviolet light as the atherium bromide will fluoresce, take a picture of the image and compare fluorescent intensities of the purified RNA from each condition.
To perform RNA quantification using UV v spectroscopy, place two microliters of water on an NanoDrop 2000 or similar machine and measure the blank. Next place two microliters of each RNA sample following purification on the spectrophotometer and measure the ultraviolet visible light from a wavelength range of 200 nanometers to 800 nanometers in the case that absorbance is above an optical density of one. Dilute the samples in nuclease free water to obtain an optical density less than one.
Finally, use graphing software to plot the various samples and compare the optical density at 260 nanometers aros gel electrophoresis is used to image the transcribed RNA. If the complex inhibits RNA transcription, the production of RNA is reduced and theban will appear lighter. Actin d and tryptoline show a clear decrease of RNA when compared to the control as expected of these long studied inhibitors.
The Gallium TPFC band also has a very low level of RNA while the TPFC band shows little to no inhibition and exhibits the same relative intensity as the control UV vs. Measurements were taken for each sample. After undergoing RNA transcription for four hours and purified with RNA spin column chromatography, the spectra of wavelengths 220 nanometers to 350 nanometers are shown here.
Three of the four inhibitor treated transcription reactions yielded less RNA than the control with gallium TPFC treated DNA transcribing only one 14th as much RNA as the untreated D-N-A-T-P-F-C treated DNA showed no apparent inhibition. Thus, cytotoxicity in cell lines treated with TPFC is not due to RNA transcription inhibition. All samples have an absorbance of 260 over 280 nanometers ratio of approximately 2.2 indicating relatively pure samples.
Following this procedure, other variables in the reaction like concentration and order of addition can be tested in order to answer additional questions like mechanism of action. After watching this video, you should have a good understanding of how to determine whether your anti-cancer compound inhibits RNA transcription. Don't forget that athe bromide can be extremely hazardous for your health.
Always wear appropriate personal protective equipment and never microwave solutions or agros that contain Athene bromide.
View the full transcript and gain access to thousands of scientific videos
This article presents a detailed protocol for evaluating the ability of potential anticancer compounds, specifically corrole derivatives, to inhibit RNA transcription in vitro. The method combines RNA transcription assays with gel electrophoresis and UV-Vis spectroscopy to assess the inhibitory effects of candidate compounds and known inhibitors, providing insights into their mechanisms of action.
Discovery-stage oncology programs require robust, quantitative assays to evaluate transcriptional inhibition by novel compounds. This in vitro enzymatic assay enables direct measurement of RNA synthesis inhibition, supporting mechanistic de-risking and target validation for anticancer candidates. The approach provides actionable data for early portfolio triage and prioritization of compounds with selective transcriptional effects.
This assay fits within the early discovery to lead identification continuum, providing a mechanistic filter before preclinical model evaluation.